Please assess the completion status of the following clinical trial:

Trial Title: BREADS: Breast Adjuvant Diet Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Histologically confirmed breast cancer~* Planning to start adjuvant hormonal therapy using an aromatase inhibitor or has started adjuvant hormonal therapy using an aromatase inhibitor~* Able to read, write, and understand English~* BMI ≥ 24 kg/m2~* Age ≥ 18 years~* ER and/or PR positive (defined as having ≥ 1% staining for ER and/or PR on IHC)~* Post-menopausal~  * The absence of menstrual cycles in women who have not undergone hysterectomy for at least 12 months preceding cancer diagnosis OR~ * History of a bilateral oophorectomy OR~ * History of a hysterectomy and age \>55 OR~ * No menses for \<1 year with FSh and estradiol levels in postmenopausal range according to institutional standards~* ECOG Performance Status 0 or 1~* Female~* Written informed consent obtained from subject and ability for subject to comply with requirements of the study~Exclusion Criteria:~* Use of hormonal therapy other than aromatase inhibitors~* History of other malignancy within the past 5 years, except for malignancies with a \> 95% likelihood of cure (e.g. thyroid cancer, non-melanoma skin cancer)~* Already consuming a severe carbohydrate restricted (\<20 g carbohydrates per day) diet or vegetarian diet~* Currently on or plans to start chemotherapy (HER2/neu targeted therapy okay)~* Medical comorbidities that in the opinion of the investigator limits the patient's ability to complete the study~* Symptomatic metastases (Metastases allowed if asymptomatic)~* Current use of appetite suppressant medications~* Current use of any weight loss medications including herbal weight loss supplements or if patients are enrolled in a diet/weight loss program

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Dietary intervention (Type: EXPERIMENTAL): Carbohydrate restricted dietary intervention (\<20 g carbohydrates/day) + standard of care aromatase inhibitors
- No dietary intervention (Type: ACTIVE_COMPARATOR): Standard of care aromatase inhibitors

Based on this trial design, predict the completion outcome and termination type (if applicable).